Replies to post #9647 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

Curious that there have been no 10b5-1 sales during September: #msg-79723828.

[DewDiligence]

MNTA Insider Shareholdings

[Updated for SEC filings through 11/27/12.]


The table entries below include both ordinary and restricted
shares and both vested and non-vested options.

 
                             Shares    Options 
 Officers 
 *Craig Wheeler (CEO)       545,391    902,000 
 *G Venkataraman (SVP/R&D)  409,305    209,003 
 *John Bishop (SVP/Pharma)   92,136    146,530 
 *Richard Shea (CFO)        140,947    245,650 
 *Bruce Leicher (Gen Cnsl)  100,144    190,228 
 *James Roach (CMO)          77,474    239,611 
  
 Directors 
 John Clarke                 69,123    161,500 
 Bruce Downey                     0     80,500 
 Marsha Fanucci                   0    161,500 
 Peter Hutt                   5,365    166,500 
 Thomas Koestler                  0     47,750 
 *Bennett Shapiro             7,000    140,700 
 *Elizabeth Stoner            9,849     89,701 
 James Sulat                 10,000     85,500 
 ======================== =========  ========= 
 All fourteen insiders    1,466,734  2,866,403

*10b5-1 selling plan in effect.